{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T07:23:05Z","timestamp":1787901785235,"version":"build-2784847793"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1097\/pat.0b013e3283484a60","type":"journal-article","created":{"date-parts":[[2011,6,11]],"date-time":"2011-06-11T06:53:01Z","timestamp":1307775181000},"page":"459-464","source":"Crossref","is-referenced-by-count":69,"title":["Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas"],"prefix":"10.1016","volume":"43","author":[{"given":"Till Sebastian","family":"Clauditz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren","family":"Reiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linn","family":"Gravert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Gnoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Christina","family":"Tsourlakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"M\u00fcnscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Bokemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainald","family":"Knecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar","family":"Wilczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/PAT.0b013e3283484a60_bib0005","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1200\/JCO.2003.01.504","article-title":"Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer","volume":"21","author":"Mendelsohn","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0015","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1053\/hupa.2003.60","article-title":"Evaluation of HER-2\/ neu oncogene status in breast tumors on tissue microarrays","volume":"34","author":"Zhang","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0020","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3816\/CBC.2005.n.026","article-title":"Evaluation of clinical outcomes according to HER2 detection by fluorescence in situ hybridization in women with metastatic breast cancer treated with trastuzumab","volume":"6","author":"Mass","year":"2005","journal-title":"Clin Breast Cancer"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0025","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/sj.bjc.6600286","article-title":"Evaluation of HER-2\/neu gene amplification and protein expression in non-small cell lung carcino-mas","volume":"86","author":"Hirsch","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0030","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.humpath.2008.11.014","article-title":"HER-2 amplification is highly homo-genous in gastric cancer","volume":"40","author":"Marx","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0035","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2407-9-6","article-title":"Evalua-tion of gene amplification and protein expression of HER-2\/neu in eso-phageal squamous cell carcinoma using fluorescence in situ hybridization (FISH) and immunohistochemistry","volume":"9","author":"Sato-Kuwabara","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0040","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1158\/1078-0432.CCR-03-0253","article-title":"HER2 expression in salivary gland carcinomas: dependence on histological subtype","volume":"10","author":"Glisson","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0045","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa052122","article-title":"Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer","volume":"353","author":"Romond","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0050","series-title":"Press Release 24-27 April 2006.","article-title":"Committee for Medical Products for Human Use","year":"2006"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0055","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1245\/s10434-009-0766-0","article-title":"Targeting gastric cancer with trastuzumab: new clinical practice and innovative developments to overcome resistance","volume":"17","author":"Roukos","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0060","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00106-007-1666-x","article-title":"Prognostic value of immunohistochemistry in salivary gland cancer. (German.)","volume":"56","author":"Ettl","year":"2008","journal-title":"HNO"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0065","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/BF00718645","article-title":"Immunohistochemical expression of epidermal growth factor receptor in salivary gland tumours","volume":"415","author":"Yamada","year":"1989","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0070","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S1368-8375(03)00097-6","article-title":"Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study","volume":"39","author":"Haddad","year":"2003","journal-title":"Oral Oncol"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0075","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/hed.20714","article-title":"Successful treatment of pulmonary metastatic salivary ductal carcinoma with trastuzumab-based therapy","volume":"30","author":"Prat","year":"2007","journal-title":"Head Neck"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0080","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/hed.20614","article-title":"Salivary duct carcinoma: a clinical and histologic review with implications for trastuzumab therapy","volume":"29","author":"Nabili","year":"2007","journal-title":"Head Neck"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0085","first-page":"844","article-title":"Tissue microarrays for highthroughputmolecularprofiling oftumorspecimens","volume":"4","author":"Kononen","year":"1998","journal-title":"NatMed"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0090","first-page":"803","article-title":"Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays","volume":"59","author":"Bubendorf","year":"1999","journal-title":"Cancer Res"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0095","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s10549-009-0675-8","article-title":"Gene amplification in ductal carcinoma in situ of the breast","volume":"123","author":"Burkhardt","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0100","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/PAI.0b013e31802e91b2","article-title":"Her-2\/neu expression in salivary duct carcinoma: an immunohistochemical and chromogenic in situ hybridization study","volume":"16","author":"Johnson","year":"2008","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0105","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/archotol.133.10.1031","article-title":"Amplification and overexpression of HER2\/neu gene and HER2\/neu protein in salivary duct carcinoma of the parotid gland","volume":"133","author":"Cornolti","year":"2007","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0110","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1002\/cncr.21116","article-title":"Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases","volume":"103","author":"Jaehne","year":"2005","journal-title":"Cancer"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0115","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.1365-2559.2003.01600.x","article-title":"Expression of HER-2\/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in-situ hybridization and immunohistochemistry","volume":"42","author":"Skalova","year":"2003","journal-title":"Histopathology"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0120","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2559.2004.01781.x","article-title":"Expression of HER-2\/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in-situ hybridization and immunohistochemistry","volume":"44","author":"Dagrada","year":"2004","journal-title":"Histopathology"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0125","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.oraloncology.2009.05.635","article-title":"Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs)","volume":"45","author":"Locati","year":"2009","journal-title":"Oral Oncol"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0130","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1055\/s-2001-17088","article-title":"About the prognostic value of Her-2 gene-amplification and cell-proliferation in salivary duct carcinoma of the major salivary glands - a pilot-study","volume":"80","author":"Jaehne","year":"2001","journal-title":"Laryngorhinootologie"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0135","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/jcp.56.12.914","article-title":"Salivary duct carcinoma: immunohistochemical profile of an aggressive salivary gland tumour","volume":"56","author":"Etges","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0140","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1017\/S0022215108002314","article-title":"Biological therapy of salivary duct carcinoma","volume":"123","author":"Nashed","year":"2009","journal-title":"J Laryngol Otol"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0145","first-page":"435","article-title":"Epidermal growth factor receptor and human epidermal growth receptor 2 expression in parotid mucoepidermoid carcinoma: possible implications for targeted therapy","volume":"19","author":"Shang","year":"2008","journal-title":"Oncol Rep"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0150","first-page":"5675","article-title":"Amplification and overexpression of HER-2\/neu in carcinomas of the salivary gland: correlation with poor prognosis","volume":"54","author":"Press","year":"1994","journal-title":"Cancer Res"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0155","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3346\/jkms.1997.12.6.499","article-title":"Mucoepidermoid carcinoma of the salivary gland-a clinico-pathologic and immunohistochemical study for c-erbB-2 oncoprotein","volume":"12","author":"Cho","year":"1997","journal-title":"J Korean Med Sci"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0160","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1017\/S0022215100142148","article-title":"Histological features and prognosis of patients with mucoepidermoid carcinoma of the parotid gland","volume":"112","author":"Suzuki","year":"1998","journal-title":"J Laryngol Otol"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0165","series-title":"Approval Letter P980018\/S010 HercepTest.","first-page":"1","year":"2010"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0170","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/hed.21052","article-title":"Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib","volume":"31","author":"Vidal","year":"2009","journal-title":"Head Neck"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0175","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0194-5998(95)70272-5","article-title":"c-erbB-2\/neu oncogene and Ki-67 analysis in the assessment of palatal salivary gland neoplasms","volume":"112","author":"Giannoni","year":"1995","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0180","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2310\/7070.2003.11438","article-title":"HER2\/neu and Ki-67 as prognostic indicators in mucoepidermoid carcinoma of salivary glands","volume":"32","author":"Nguyen","year":"2003","journal-title":"J Otolaryngol"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0185","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hed.10387","article-title":"MUC4 and ERBB2 expression in major and minor salivary gland mucoepidermoid carcinoma","volume":"26","author":"Weed","year":"2004","journal-title":"Head Neck"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0190","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2559.2008.03159.x","article-title":"Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas","volume":"53","author":"Ettl","year":"2008","journal-title":"Histopathology"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0195","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1258\/0022215041615191","article-title":"Neck dissection findings in primary head and neck high-grade adenocarcinoma","volume":"118","author":"Sheahan","year":"2004","journal-title":"J Laryngol Otol"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0200","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1200\/JCO.2007.14.8197","article-title":"Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations","volume":"27","author":"Sauter","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0205","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/hed.21277","article-title":"Expression of matrix metalloproteinase- 1, -7, -9, -13, Ki-67, and HER-2 in epithelial-myoepithelial salivary gland cancer","volume":"32","author":"Luukkaa","year":"2010","journal-title":"Head Neck"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0210","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/modpathol.3800729","article-title":"Close association between HER-2 amplification and overexpression in human tumors of non-breast origin","volume":"20","author":"Tapia","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1097\/PAT.0b013e3283484a60_bib0215","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0039-128X(02)00039-9","article-title":"Comparison of different antibodies for detection of progesterone receptor in breast cancer","volume":"67","author":"Press","year":"2002","journal-title":"Steroids"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516329786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516329786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T02:02:27Z","timestamp":1628215347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516329786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0031302516329786"],"URL":"https:\/\/doi.org\/10.1097\/pat.0b013e3283484a60","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}